UPDATE
: Thursday, December 5, 2019
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Regulator finds no trace of carcinogen in GSK’s heartburn drug
The Ministry of Food and Drug Safety said that it has failed to find the tr...
by Lee Han-soo
|
2019-09-17 16:27
라인
Regulator inspects heartburn drugs after US finds carcinogen
After U.S. health officials said they detected low levels of a potentially ...
by Lee Hye-seon
|
2019-09-16 14:01
라인
FDA warns against pneumonitis with CDK 4/6 inhibitor drugs for breast cancer
The U.S. Food and Drug Administration added a warning that the entire class...
by Kim Yun-mi
|
2019-09-16 11:39
라인
Number of antibiotic-resistant infections increase faster than 2018
The number of patients infected with Carbapenem-resistant Enterobacteriacea...
by Lee Han-soo
|
2019-09-12 07:23
라인
KCDC pegs salted clam as culprit behind hepatitis A rise
The Korea Centers for Disease Control and Prevention (KCDC) said that it ha...
by Lee Han-soo
|
2019-09-12 07:22
라인
Korea sees a spike in depression, bipolar disorder
The number of depression and bipolar disorder patients is steadily increasi...
by Lee Han-soo
|
2019-09-11 15:16
라인
Drug safety institute conducts APEC program
The Korea Institute of Drug Safety and Risk Management (KIDS) said that it ...
by Lee Han-soo
|
2019-09-06 14:53
라인
‘Government is doing best to relieve pain of atopic dermatitis patients’
The Health Insurance Review and Assessment Service (HIRA) held a closed-doo...
by Kim Yun-mi
|
2019-09-05 11:48
라인
Biohealth R&D budget up 16% next year
The government said it would make a public-private joint system to innovate...
by Kwak Sung-sun
|
2019-09-04 15:14
라인
Health insurance agency invites officials from African countries
The National Health Insurance Service (NHIS) and the Korea Foundation for I...
by Lee Han-soo
|
2019-09-03 15:09
라인
Multiple myeloma treatment isatuximab named orphan drug
The drug regulator designated isatuximab, a treatment for relapsed and refr...
by Lee Hye-seon
|
2019-09-03 11:21
라인
‘Vaping reduces harm from tobacco’
The health authorities need a smoking cessation policy that promotes the us...
by Park Gi-taek
|
2019-08-29 15:33
라인
Korea seeks healthcare ties with Vietnam under New Southern Policy
The Moon Jae-in administration has begun to push for New Southern Policy, p...
by Kwak Sung-sun
|
2019-08-28 16:03
라인
‘Ministry to provide quick measures for users of Allergan’s breast implants’
Fear is spreading among Korean women who received Allergan’s specific breas...
by Lee Hye-seon
|
2019-08-21 15:20
라인
Number of drug addicts reached 77,000 in past 5 years
Drug abuse is emerging as a serious problem in Korea with the number of dru...
by Lee Han-soo
|
2019-08-19 18:00
라인
Korea to provide ₩100 billion annually for 3 new industries
The government said it would prove more than 100 billion won ($82.4 million...
by Song Soo-youn
|
2019-08-14 14:52
라인
Drug regulator to enhance clinical trial management by 2023
The Ministry of Food and Drug Safety on Thursday announced a “Comprehensive...
by Lee Hye-seon
|
2019-08-08 14:55
라인
Japan’s 'whitelist’ removal to have minimal effect on biopharmaceutical sector
The local biopharmaceutical industry expects that Japan’s decision to remov...
by Lee Han-soo
|
2019-08-02 17:14
라인
Childbirth continues to hit new lows in Korea
The number of births and marriages hit new lows in May, as Korea's chil...
by Lee Han-soo
|
2019-08-01 18:09
라인
Pfizer's Besponsa, Takeda's Zejula likely to get insurance coverage
Pfizer's Besponsa, a B-cell lymphoblastic leukemia treatment, and Taked...
by Lee Han-soo
|
2019-07-26 17:57
-
1
2
3
4
5
6
7
8
9
10
다음
-
Korea exports health insurance system to Bahrain
‘Lynparza raises value of precision medicine as anticancer treatment’
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Roche Diagnostics stresses ‘integrated personalized diabetes management’
Korea exports health insurance system to Bahrain
‘Lynparza raises value of precision medicine as anticancer treatment’
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports
Roche Diagnostics stresses ‘integrated personalized diabetes management’
여백
Most viewed
1
Syntekabio views industry’s crisis as opportunity
2
S. Biomedics to test embryonic stem cell-derived spinal cord injury treatment
3
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan
4
Technology developed to detect inflammatory disorders early
5
GC MS wins US patent for influenza diagnostic technology
6
‘Obesity needs to be treated as a chronic disease’
7
Alteogen inks licensing-out deal for SC injection formulation technology
8
[Special] Trainee doctors fear medical mishaps amid severe shortage of workforce
9
Samyang Biopharm’s US subsidiary to work on new immunotherapy
10
Swedish researchers divide Type 2 diabetes into 5 subgroups
여백
Opinion
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Reporter’s Notebook] SillaJen should be ashamed of itself
여백
Back to Top